1 May 2018; pdfCompany Announcement – Pro Medicus Signs 5-year Visage RIS Deal with I-MED Radiology – Acrobat pdf 259k


  • I-MED to standardise on Visage RIS across all 200 practices
  • I-MED’s Regional Imaging (RIL) and Queensland businesses to transition to Visage RIS over next 12 months
  • New sites to add an additional $1.4 million in revenue per annum
  • Contracts for existing Visage RIS sites to be extended for a further 5 years
  • Potential for upside as I-MED continues to grow
  • Once completed, will be one of the largest RIS installations globally

Leading healthcare imaging company Pro Medicus Limited [ASX: PME] today announced it has signed a five-year agreement with I-MED Radiology Network (I-MED), that will see I-MED standardise on Visage RIS across all of its practices.

I-MED, Australia’s largest diagnostic imaging provider, performs over 4.6 million patient procedures annually across New South Wales, ACT, Victoria, Tasmania, Northern Territory and Queensland.

As part of this agreement, I-MED will transition its Regional Imaging (RIL) and Queensland practices to Visage RIS over the next 12 months. This is expected to deliver an additional $1.4 million per annum revenue once these sites are fully implemented. In addition, I-MED will extend its existing Visage RIS contract for the Victorian, NSW and ACT operations for a further 5 years.

Dr Sam Hupert, CEO of Pro Medicus said, “I-MED is the largest diagnostic imaging provider in Australia and with this deal we further cement our position as leaders in the Australian RIS market. Once completed, this will be one of the largest RIS installations in the world.”

I-MED Chief Executive Steven Rubic said, “We were keen to consolidate our systems into a single, national platform that would provide us with significant cost synergies as well as support our strategic objectives. It was therefore vital that the system we chose not only had the functionality and scalability to handle a group of our size and complexity but also had the capacity to cater for significant growth. We believe Visage RIS is well placed to handle these requirements.”

Implementation of RIL and I-MED Queensland is scheduled to commence toward the first half of FY2019 and is estimated to take up to 12 months. The five-year contract will follow implementation and has potential for upside as I-MED continues to grow its radiology business.

“This deal rewards our considerable investments in Visage RIS,” said Dr Sam Hupert. “We have a compelling platform for the rapidly consolidating radiology industry and are well positioned to service those opportunities.”